Clinical Trial Update: A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

This entry documents the completion of a Phase 2 trial evaluating Rituximab in adults with relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED